Document is current
Any future updates will be listed below
-
Authors
Volpe, B. https://orcid.org/0009-0007-1125-9295
Vermorken, B. L.
Van Boxel, S. C. J.
Guinand, N.
Pérez Fornos, A.
Devocht, E. M. J.
van de Berg, R.
-
Funding
Funding for this research was provided by:
Stichting De Weijerhorst
MED-EL
ZonMW
- License Information
-
More Information
Article History
Received: 27 July 2025
Revised: 6 October 2025
Accepted: 7 October 2025
First Online: 4 November 2025
Declarations
:
: The authors have no competing interests to declare.
: The protocol of the VertiGo! trial (ClinicalTrials.gov Identifier: NCT04918745) was approved by and carried out in accordance with the recommendations of the local ethics committee (Maastricht University Medical Center, NL73492.068.20/METC 20-087). The study was designed in accordance with the Declaration of Helsinki. Patients provided written informed consent prior to participation and were compensated for their traveling and accommodation expenses.
